Table 3.
Ongoing clinical trials regarding radiotherapy in the treatment of liver metastases.
| Trial | Timing | Method | Dose | Outcomes | Reference |
|---|---|---|---|---|---|
| NCT01318447 | Start: January, 2011, interim: January, 2014, complete: January, 2017 | Phase II, SBRT | BED10 = 112, SBRT | Response, toxicity, local control, survival, quality of life | Clinicaltrials.gov (2011a) |
| NCT00923897 | Start: February, 2007, complete: November, 2012 | Phase II | BED10 = 14.4, conventional RT | Quality of life | Clinicaltrials.gov (2011b) |
| NCT01162278 | Start: July, 2010, interim: July, 2014, complete: July, 2018 | Phase I | BED10 = 157.5–300, SBRT | Safety response, toxicity, local control, survival | Clinicaltrials.gov (2011c) |
| NCT00914615 | Start: August, 2007, complete: August, 2010 | Phase II | (Not provided) | Toxicity, survival, quality of life, cytokine, response | Clinicaltrials.gov (2011d) |